cura

Search documents
Por que seus relacionamentos são o melhor remédio | Simone Nascimento | TEDxGuararema
TEDx Talks· 2025-07-01 16:51
O que mata mais do que o cigarro é mais perigoso do que o colesterol alterado e ameaça nossa longevidade, nossa expectativa de vida, mais do que a nossa pressão arterial descontrolada. A resposta para essa pergunta pode surpreender vocês, é a solidão. Bem-vindos à ciência revolucionária da longevidade relacional, que mostra que a conexão humana é muito mais do que um prazer da vida ou boa companhia.É uma necessidade vital. Tem um ditado que vocês devem conhecer que diz que sozinhos nós vamos mais rápido, ma ...
Sporcarsi le mani: il prezzo per la felicità | Gabriele Novaria | TEDxYouth@AlberghieroRosmini
TEDx Talks· 2025-06-27 15:33
[Musica] [Musica] Oh. Buongiorno a tutti. Rompere il ghiaccio, vorrei raccontarvi qualcosa su di me.So che probabilmente a pochi di voi interesserà, però io sono sul palco e le racconto lo stesso. Il mio piatto preferito sono le lasagne, il mio dolce preferito è il tirami su. L'ultimo libro che ho letto è stata la biografia di Ninofassica e ultimamente ho cambiato il sapore, il gusto del dentifricio da menta allo zenzero e non mi piace assolutamente.Non vedo l'ora di cambiare il tubetto e ritornare alla men ...
Princess Cruises Toasts Top Wine Honors with 16 Wine Spectator Awards of Excellence for 2025
Prnewswire· 2025-06-26 14:00
Dining Rooms Across All 16 Ships, Including 15 Main Dining Rooms and the Sanctuary Collection Restaurant on Sun Princess, Recognized for Outstanding Wine ListsFORT LAUDERDALE, Fla., June 26, 2025 /PRNewswire/ -- Princess Cruises is once again raising a glass to excellence, as all 16 ships in its fleet have earned the prestigious Wine Spectator Award of Excellence in the publication's 2025 Restaurant Awards. Now a two-time winner, 15 Princess main dining rooms were recognized, alongside the Sanctuary Collect ...
National Advertising Division Finds Certain Verizon Satellite Texting Claims Supported; Recommends Modified Disclosures for Others
GlobeNewswire News Room· 2025-06-18 15:32
Core Viewpoint - The National Advertising Division (NAD) found that Verizon's claims regarding its Satellite Texting services and "largest network" advertising were partially supported but recommended modifications for clearer disclosures in future advertising [1][5][8]. Satellite Claims - NAD reviewed Verizon's claims that it is "conquering dead zones with satellite" and found that these claims do not imply exclusivity over the functionality [2][3]. - The partnership with AST SpaceMobile, currently in testing, does not substantiate the claims made by Verizon regarding satellite texting [3]. - A previous commercial's disclosure about satellite connectivity was deemed insufficiently clear regarding the requirement for newer phone models [4]. - NAD concluded that while Verizon has a reasonable basis for its satellite claims, future advertising must include clear and conspicuous disclosures about the availability of satellite texting features [5]. "Largest Network" Claims - T-Mobile challenged Verizon's claim of having "America's largest network," arguing that this typically refers to geographic coverage rather than subscriber numbers [6]. - NAD found the term "largest network" ambiguous and noted that "postpaid phone connections" may not clearly indicate Verizon subscribers [7][8]. - NAD recommended that Verizon modify its disclosure to clarify what "postpaid phone connections" refers to, ensuring that the claims can be substantiated with appropriate qualifications [8]. Compliance and Discontinuation - Verizon has permanently discontinued the challenged implied claims related to satellite-supported texting and its wireless network, and NAD will treat these claims as recommended for discontinuation for compliance purposes [9]. - Verizon stated it will comply with NAD's recommendations regarding advertising practices [9].
X @Tesla Owners Silicon Valley
Tesla Owners Silicon Valley· 2025-06-15 16:23
“When you think about a news story about something you know well, how accurate is that news story about something you know well? I think you'll find that it's actually not very accurate.That's true for everything. There's a desperate quest for clicks. The more crazy the headline is, the more clicks it will get.”Elon Musk ...
New High Accuracy Current Sense Amps Compatible with Both Negative and High Voltages
Globenewswire· 2025-06-11 21:00
ROHM's New Lineup of High Accuracy Current Sense Amps The BD1423xFVJ-C and BD1422xG-C series are qualified under the AEC-Q100 automotive reliability standard. Current Sense Accuracy Comparison ROHM's new current sense amplifier IC vs conventional configuration Santa Clara, CA and Kyoto Japan, June 11, 2025 (GLOBE NEWSWIRE) -- ROHM Semiconductor today announced they have developed a new lineup of high accuracy current sense amps – the BD1423xFVJ-C and the BD1422xG-C. Both series are qualified under ...
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
Globenewswire· 2025-06-11 10:00
– 7 of 8 myositis patients achieved clinically meaningful TIS responses after discontinuation of all immunomodulators, while off or actively tapering steroids; responses were sustained throughout the follow-up period in all responding patients – – All SLE patients without nephropathy achieved definition of remission in SLE (DORIS) as of the latest follow-up, and all 7 SLE and LN patients experienced SLEDAI-2K reductions, while off all immunomodulators and steroids – – Both scleroderma patients demonstrated ...
Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
GlobeNewswire News Room· 2025-05-15 11:00
– SLE and LN registrational discussions with FDA anticipated in 3Q25; systemic sclerosis registrational discussions with FDA anticipated in 4Q25 – – New clinical data on rese-cel in myositis, SLE / LN and systemic sclerosis to be presented in three oral sessions at the EULAR 2025 Congress in June – – Two subtype specific cohorts with ~15 patients each added to the ongoing RESET-Myositis™ trial – As of March 31, 2025, the Company had cash and cash equivalents of $131.8 million, per our Form 10-Q being filed ...
Magnite (MGNI) FY Conference Transcript
2025-05-13 15:15
Magnite (MGNI) FY Conference May 13, 2025 10:15 AM ET Speaker0 Thank you. It is your stage. Well done. Speaker1 So this is Michael Barrett. He's the CEO of Magnite, and we have the CFO, David Day, and we have the head of SVP of IR. Speaker0 And real estate. Speaker1 And real estate. And he keeps having titles. Like, who do keep up with this title? Empire under construction. Okay. I'm Laura Martin of, Needham, the senior Internet and media analyst. I'm here with Michael Barrett on stage. And, so we just had ...
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
Benzinga· 2025-05-05 11:30
U.S. stocks settled higher on Friday following the release of jobs data, with the S&P 500 recording gains for the ninth consecutive day to notch its longest winning streak since Nov. 2004.All three major averages recorded gains for the second week, with the S&P 500 adding 2.9% and the Dow gaining 3% on the week. The Nasdaq, meanwhile, closed higher by 3.4% for the week.Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track ...